Autres langues Quest PharmaTech Inc.

Actions

QPT

CA74836M1068

Marché Fermé - Toronto S.E. Autres places de cotation 21:59:59 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,035 ^CAD	+16,67 %		+16,67 %	-36,36 %

23/01	Quest PharmaTech Inc. reçoit les recommandations du comité de surveillance des données de sécurité d'interrompre l'étude clinique de phase III sur l'oregovomab	CI
2023	Quest PharmaTech Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 octobre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes	30/01
Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000	30/01
Quest Receives Cash Dividend Payment from OncoQuest	30/01
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	24/01
Quest PharmaTech Inc. - Oregovomab Phase III Clinical Study fails futility analysis, Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	24/01
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	23/01
Quest PharmaTech Inc. Receives Recommendations from the Data Safety Monitoring Board to Discontinue Oregovomab Phase III Clinical Study	23/01
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	13/12
Quest PharmaTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	21/09/23
Quest PharmaTech Provides Corporate Update	13/09/23
Quest PharmaTech Announces Results from AGM	14/07/23
Quest PharmaTech Provided Product Development Update	10/07/23
Quest PharmaTech Provides Product Development Update	10/07/23
Quest PharmaTech Inc. Provides Product Development Update	10/07/23
Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	29/06/23
Quest PharmaTech Provides Corporate Update	09/06/23
Canadian Investment Regulatory Organization Trade Resumption - QPT	07/06/23
Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.	06/06/23
Canadian Investment Regulatory Organization Trading Halt - QPT	06/06/23
Quest PharmaTech Provides Corporate Update	02/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Quest PharmaTech Inc.

Actions

QPT

CA74836M1068

Autres langues

Filtres